Denied a GLP-1 for PCOS or Fertility Issues? Here's What You Need to Know
Denied a GLP-1 for PCOS or Fertility?
Women with PCOS and fertility struggles are seeing results with GLP-1 medications — but many are still being denied coverage. Here's what you need to know.
If you've been trying to get pregnant and struggling with PCOS or weight-related fertility issues, you've probably heard the buzz about "Ozempic babies." Women who had been told for years they might never conceive are suddenly announcing pregnancies after starting GLP-1 medications.
It's not a fluke. And it's not magic. There's real science behind it — even if researchers are still catching up to what women are experiencing firsthand.
The frustrating part? Many women with PCOS are still being denied GLP-1 coverage by insurance, even though semaglutide was added to the official PCOS treatment guidelines in 2023.
The "Ozempic Baby" Phenomenon Is Real
Doctors are noticing. Reproductive endocrinologists at Cleveland Clinic have said it's "not an overstatement" that there's an Ozempic baby boom happening right now.
Women are sharing their stories on TikTok, Reddit, and Instagram under hashtags like #OzempicBaby and #OzempicPregnancy. Many had struggled with infertility for years. Some had been told by doctors they might never conceive due to PCOS.
Then they started a GLP-1 medication — often for weight loss or diabetes management — and within months, they were pregnant.
One woman told CNN she had been trying to conceive for over two years and had been "severely depressed" after doctors said PCOS might prevent her from ever getting pregnant. Five months after starting Mounjaro, she conceived.
How GLP-1s May Improve Fertility
These medications don't directly boost fertility. There's no evidence that Ozempic or Mounjaro act on the reproductive system to make you more fertile.
What they do is help with several underlying conditions that tank fertility:
PCOS, GLP-1s, and the Insurance Denial Problem
Here's the catch: despite semaglutide being included in the 2023 PCOS Treatment Guidelines, many insurers still won't cover GLP-1 medications unless you have a Type 2 diabetes diagnosis.
That means women with PCOS — a condition that affects 7-10% of women of reproductive age in the U.S. and is one of the most common causes of infertility — often can't access a medication that's been shown to help their condition.
If you have PCOS and have been denied coverage for a GLP-1, you have options:
Option 1: Appeal the Denial
Work with your doctor to submit an appeal with documentation showing your PCOS diagnosis and supporting evidence for GLP-1 treatment. Include any relevant lab work (A1C, fasting insulin, hormone panels) and reference the 2023 treatment guidelines.
This can work, but it takes time — often weeks or months — and there's no guarantee.
Option 2: Manufacturer Patient Assistance Programs
Novo Nordisk (Ozempic/Wegovy) and Eli Lilly (Mounjaro/Zepbound) both offer savings programs, though eligibility varies and they typically don't cover the full cost for uninsured patients.
Option 3: Telehealth Providers
This is often the fastest path to access. Several telehealth platforms now specialize in GLP-1 prescriptions and don't require a diabetes diagnosis. Many offer:
- Virtual consultations with licensed providers
- Transparent monthly pricing
- Compounded semaglutide or tirzepatide options at lower cost
- No insurance required
💡 Telehealth Is Usually the Fastest Option
Real prescription, medical oversight, medication shipped to your door.
What to Expect: Cost Without Insurance
Let's be real about pricing. Brand-name GLP-1s without insurance run $900-1,500+/month. That's out of reach for most people.
Telehealth providers offering compounded versions typically charge $150-450/month depending on the medication and dose. It's still a significant expense, but far more accessible than retail pricing.
⚠️ Important Safety Information
Before you start a GLP-1 with fertility in mind, there are critical safety considerations:
Frequently Asked Questions
The Bottom Line
GLP-1 medications aren't fertility drugs. But for women whose fertility has been impacted by PCOS, obesity, or insulin resistance, these medications can help address the underlying metabolic issues that were preventing pregnancy.
The research is still catching up to the anecdotal evidence, but the mechanism makes sense: fix the metabolic dysfunction, and the reproductive system often follows.
If you've been denied access to a GLP-1 for PCOS or weight management, don't give up. There are pathways to access these medications — and for some women, they've been life-changing.
Take the Next Step
Thousands of women with PCOS have found access to GLP-1 medications through telehealth providers — no insurance battles required.
Compare Providers & Get Started →This article is for informational purposes only and is not medical advice. Always consult with your healthcare provider before starting or stopping any medication, especially if you're trying to conceive or are pregnant.